Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Breast Cancer
•
Radiation Oncology
What do you quote as the risk of lymphedema following axillary dissection with lymphovenous bypass and regional nodal radiotherapy for breast cancer?
Related Questions
How do you approach breast RT in a patient with a recent history of ipsilateral thoracic irradiation?
What is the current paradigm for breast cancer diagnosed with isolated metastases prior to initial treatment?
How do you approach capsular contracture after breast radiotherapy?
In what clinical scenario, if any, would you consider APBI appropriate treatment for a patient with triple-negative breast cancer?
What pentoxifylline and vitamin E dose do you typically use for both the prevention and treatment of radiation-associated fibrosis after breast RT?
When treating breast cancer patients with RNI, how often do you include internal mammary nodes?
What dose constraints do you when treating a patient with bilateral breast cancers with RNI?
Do you offer APBI to patients with close margins?
How would you manage a left sided triple negative breast cancer with a concurrent left sided locally advanced non-small cell lung cancer?
Would you offer PMRT to a young patient with a remote history of mantle/lung RT for Hodgkins lymphoma and a left cT0N1 triple positive breast cancer with a complete response after neoadjuvant chemotherapy?